Abstract
OBJECTIVES
Genome-wide association studies (GWAS) have identified consistent associations with obesity, with a number of studies implicating eating behavior as a primary mechanism. Few studies have replicated genetic associations with dietary intake. This study evaluates the association between obesity susceptibility loci and dietary intake.
METHODS
Data were obtained as part of the Diabetes Prevention Program (DPP), a clinical trial of diabetes prevention in persons at high risk of diabetes. The association of 31 GWAS-identified obesity risk alleles with dietary intake, measured through a food frequency questionnaire, was investigated in 3,180 participants from DPP at baseline.
Results
The minor allele at BDNF, identified as protective against obesity, was associated with lower total caloric intake (β=−106.06, SE=33.13; P=0.0014) at experiment-wide statistical significance (P=0.0016), while association of MC4R rs571312 with higher caloric intake reached nominal significance (β = 61.32, SE=26.24; P=0.0194). Among non-Hispanic White participants, the association of BDNF rs2030323 with total caloric intake was stronger (β=−151.99, SE=30.09; P<0.0001), and association of FTO rs1421085 with higher caloric intake (β=56.72, SE=20.69; P=0.0061) and percentage fat intake (β=0.37, SE=0.08; P=0.0418) was also observed.
Conclusions
These results demonstrate with the strength of independent replication that BDNF rs2030323 is associated with 100 – 150 greater total caloric intake per allele, with additional contributions of MC4R and, in non-Hispanic White individuals, FTO. As it has been argued that an additional 100 kcals per day could account for the trends in weight gain, prevention focusing on genetic profiles with high dietary intake may help to quell adverse obesity trends.
Clinical Trial registration: ClinicalTrials.gov, NCT00004992
Keywords: obesity, diet, total caloric intake, diet, BDNF, MC4R, FTO
Introduction
Obesity is a major public health problem associated with increased risk for developing type 2 diabetes, cardiovascular disease and certain types of cancer [1–5]. Obesity susceptibility loci identified through genome-wide association studies (GWAS), replicated in multiple independent cohorts, have provided new insights into the genetic factors that contribute to the development of obesity [6–8]. Many of these loci are located in or nearby genes expressed in hypothalamic eating regulatory pathways, highlighting a potential role in the central nervous system and eating behavior for these genetic associations [8]. Consistent with this hypothesis, the FTO single nucleotide polymorphism (SNP) rs9939609 has been shown to predict preferences for and consumption of palatable, calorie dense foods [9,10] and reduced satiety [11], and greater total caloric and fat intake [10]. In a recent GWAS of dietary intake, FTO was associated, albeit inconsistently, with a greater percentage of calories from protein [12,13] and fat [14]. MC4R obesity risk alleles were associated with greater caloric intake and percent fat intake in the Nurses’ Health Study [15] but not in another sample of men and women [16], and obesity risk alleles at SH2B1 were associated with greater total, saturated, and monounsaturated fat intake in Dutch women [17]. In Look AHEAD [18], obesity risk alleles in FTO were significantly associated with a greater number of meals and snacks per day, with nominal associations with greater total caloric intake, greater percent calories from fat, and more servings of fats, oils and sweets. The BDNF region also predicted a variety of dietary parameters, including servings of meats, eggs, nuts and beans and servings of dairy, and with nominal associations with total caloric intake, servings of breads, cereals, rice and pasta and servings of sweets and fats [18].
In the Look AHEAD study, the BDNF region was associated with roughly 100 additional kcals of caloric intake per allele per day (or 200 kcals per day for two copies of the risk allele). The FTO region further accounted for an additional 60 kcals of caloric intake per allele per day (or 120 kcals for two copies of the risk allele). It has been argued that an additional 100 kcals per day accounts for the weight gain trends in the United States [19] with clinical programs being developed to stave off weight gain through reductions in daily energy balance by roughly 100 kcals [20,21]. As such, genetic variation that accounts for 100 kcals or more of energy intake could make a substantive contribution to weight gain with the potential of targeting such weight gain with established programs.
A prerequisite to clinical application related to genetic association studies is independent replication. Here, we seek to replicate prior associations of obesity risk SNPs with measures of dietary intake employing data from the DPP, a study of racially and ethnically diverse, mostly overweight or obese adults with elevated fasting glucose and impaired glucose tolerance.
Material and Methods
Participants
The DPP [22,23] enrolled 3,819 participants at high risk for developing diabetes due to impaired glucose tolerance and a BMI of 24 kg/m2 or higher, across 27 clinical centers throughout the U.S. Participants were randomized to placebo, metformin 850 mg twice daily, troglitzaone 400 mg once a day, or a lifestyle intervention aiming at ≥7% decrease in baseline weight. Because our goal was to replicate previous findings, we focus on baseline dietary intake prior to any intervention. Participants included in this study had diet data (N=3753), consented to genetic study (N=3550), and had successful genotyping on the Cardiometabochip after quality control measures (see below) (N=3302). The 3180 participants who met all three criteria are the focus of this study. The study began July 1996 and ended April 2001.
Measures
Standing height was determined in duplicate at baseline using a calibrated stadiometer. Weight was measured in duplicate on a calibrated balance beam scale semi-annually. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.
Dietary intake over the past year was quantified via in person interview using the DPP semiquantitative, food frequency questionnaire (FFQ) [24]. Estimates of The Food Guide Pyramid [25] food group and nutrient intake were conducted using the Health Habits and History Questionnaire (HHHQ)/DietSys software and DPP–specific programming written to incorporate the DPP modifications to the questionnaire. The nutrient database was obtained primarily from the Insulin Resistance Atherosclerosis Study [26] and the Nutrition Data System (NDS-R, Nutrition Coordinating Center, University of Minnesota, Minneapolis MN, Database version 2.6/8A/23). Number of meals and snacks per day were defined as the number of distinct eating episodes reported.
Genotyping
Genotyping was carried out using the Metabochip (Illumina, San Diego, CA (33). We excluded 19 study participants with a failed concordance test (<95%) when compared to genotyping arrays previously deployed in this cohort, samples displaying inconsistency with self-reported sex, or familial relatedness (first degree relatives). SNPs with within-study genotyping call rate <95% or marked deviation from Hardy-Weinberg equilibrium (P<10−7) in any ethnic group were also excluded. After standard quality control procedures, the genotyping success rate was >99.85% and the concordance rate was 99.88%.
SNPs derived from the obesity GWAS study by Speliotes and colleagues [6] and represented on the Metabochip were selected. Twenty-one SNPs were directly represented on the Metabochip. Ten SNPs not directly represented on the Metabochip were replaced by proxies (Closest gene and proxy SNP: FTO rs1421085; GNPDA2 rs12641981; BDNF rs2030323; NRXN3 rs17109256; RBJ rs11676272; TMEM160 rs2303108; CADM2 rs9852859; PTBP2 rs11165643; MTIF3 rs1885988; ZNF608 rs6864049, r2 ≥ 0.97) where possible using phased genotype data from the 1000 Genomes Project and the SNP Annotation and Proxy Search tool [27]. A total of 31 SNPs were included in analyses.
Statistical Analysis
Means (± standard deviations) are reported for normally distributed data, while medians (IQR) are reported for data from skewed distributions. Spearman’s correlation was used to describe the relationship between total caloric intake, BMI, and weight.
Following the analytic approach used in the Look AHEAD sample [18], analyses employed multivariable linear regression with a Huber-White sandwich estimator to evaluate the association between genotypes and dietary intake measurements [28]. This method produces standard errors robust to deviations for normality. Additive genetic models were employed unless the minor allele frequency (MAF) was < 0.20, in which case, the rare homozygous genotype was collapsed with heterozygous genotype to preserve statistical power. All models are adjusted for DPP center, sex and age at randomization. Principal components (PCs) generated from EIGENSTRAT were further included as covariates to control for population stratification [29]. Sensitivity analyses introduced weight as an additional covariate in models of total caloric intake and total caloric intake as a covariate in models of meals per day and food group servings. As allele frequencies, patterns of linkage disequilibrium and effect sizes often differ across major racial and ethnic groups, [30–32], we conducted sensitivity analyses in non-Hispanic Whites, the largest racial and ethnic subgroup in DPP. A genetic risk score was calculated by weighing the number of risk alleles at each locus by previously reported associations with body mass index [6] and summing across loci.
Beta estimates and 95% confidence intervals are reported. Bonferroni correction was used to account for multiple comparisons (P =0.05/31, or 0.0016). In addition, because these analyses are designed to replicate results from previous studies, we discuss results of nominal significance (0.0016 ≤ P < 0.05). We used SAS software v9.2 (SAS, Cary, NC) for the analysis. Analyses of a subset of the current SNPs in relation to weight have been reported previously [33]. This study was approved by the George Washington University Institutional Review Board.
Results
Characteristics of DPP participants contributing to these analyses are shown in Table 1. Participants were from diverse racial and ethnic groups (43.5% from racial ethnic minority groups), and 61.7% were women. They were on average 50.8 (SD = 10.6) years of age and had a mean BMI of 34.0 (6.6) kg/m2. Participants reported consuming a median intake of 1,898 (25th–75th percentile: 1453 – 2558) Kcal per day. A mean of 34% (7%) percent of calories were derived from fat, 49% (8%) from carbohydrate, and 17% (3%) from protein. Total caloric intake was positively associated with body weight (r = 0.22, P< 0.0001) and BMI (r = 0.15, P< 0.0001).
Table 1.
Baseline characteristics of the Diabetes Prevention Program Genetic Subsample (N=3,180)
| Characteristic | Mean ± SD, N (%), or Median (25th–75th percentile) |
|---|---|
| Age (y) | 50.8 ± 10.6 |
| Sex | |
| Males | 1047 (32.9%) |
| Females | 2133 (67.1%) |
| Self Reported Race/ethnicity | |
| Non-Hispanic White | 1796 (56.5%) |
| African American | 633 (19.9%) |
| Hispanic | 535 (16.8%) |
| Asian/Pacific Islander | 140 (4.4%) |
| American Indian | 76 (2.4%) |
| Weight (kg) | 94.4± 19.8 |
| BMI (kg/m2) | 34.0 ± 6.6 |
| Total Calories (Kcal) | 1898 (1453–2558) |
| Fat(% kcal) | 34.01 ± 6.99 |
| Carbohydrate (% kcal) | 48.88 ± 8.06 |
| Protein (% kcal) | 16.79 ± 2.79 |
| Food Group 1 - Bread, Cereal, Rice & Pasta (servings/day) | 3.40 (2.4–4.8) |
| Food Group 2 - Vegetable (servings/day) | 2.60 (1.7–3.7) |
| Food Group 3 - Fruit (servings/day) | 2.44 (1.3–3.8) |
| Food Group 4 - Milk, Yogurt & Cheese (servings/day) | 1.23 (0.7–2.1) |
| Food Group 5 - Meat/Poultry/Fish/Dry/Beans/Eggs/Nuts (servings/day) |
2.05 (1.4–3.0) |
| Food Group 6 - Fats, Oils & Sweets (servings/day) | 3.03 (1.9–4.6) |
N: number; SD: standard deviation; ; y: years; BMI: body mass index; kg: kilograms; m: meters; Kcal: kilocalorie
Total calories
In direct replication of prior research [18], obesity-related SNPs within BDNF predicted total caloric intake in the full sample (Table 2). Additional copies of the minor, or T, allele at BDNF rs2030323, identified as protective against obesity in the prior literature, were significantly associated with fewer calories per day after correction for multiple comparisons (β=−106.06, SE=33.13 daily Kcal per copy of the minor allele; P=0.0014). This effect persisted upon further adjustment for weight, although was weakened to nominal significance (β=−96.75, SE=35.31 daily Kcal per copy of the minor allele; P=0.0061).
Table 2.
Association of the minor allele at each obesity associated SNP with total caloric intake in the full sample (N=3,180).
| SNP | Closest Gene |
Minor allele |
MAF | Adjusted for age, sex, study site, PCs |
Adjusted for age, sex, study site, PCs and weight |
||||
|---|---|---|---|---|---|---|---|---|---|
| Beta* | Std Err | ProbT | Beta* | Std Err | ProbT | ||||
| rs2815752 | NEGR1 | C | 0.240 | 33.86 | 22.04 | 0.1245 | 35.47 | 20.09 | 0.0775 |
| rs1514175 | TNNI3K | C | 0.364 | −11.53 | 29.54 | 0.6964 | −6.71 | 30.72 | 0.8272 |
| rs11165643 | PTBP2 | C | 0.353 | 27.17 | 24.38 | 0.2650 | 27.07 | 23.75 | 0.2543 |
| rs543874 | SEC16B | G | 0.128 | 16.16 | 36.31 | 0.6562 | 3.95 | 35.03 | 0.9102 |
| rs2867125 | TMEM18 | A | 0.086 | 57.34 | 36.66 | 0.1178 | 62.22 | 37.16 | 0.0941 |
| rs11676272 | RBJ | A | 0.361 | −43.70 | 23.20 | 0.0596 | −43.42 | 24.01 | 0.0706 |
| rs887912 | FANCL | A | 0.139 | −59.52 | 39.37 | 0.1306 | −57.96 | 39.61 | 0.1434 |
| rs9852859 | CADM2 | C | 0.089 | −48.20 | 35.38 | 0.1730 | −45.90 | 39.31 | 0.2430 |
| rs9816226 | ETV5 | A | 0.097 | 53.06 | 38.86 | 0.1721 | 62.56 | 39.40 | 0.1124 |
| rs12641981 | GNPDA | T | 0.265 | 38.03 | 35.96 | 0.2902 | 19.73 | 33.72 | 0.5585 |
| rs13107325 | SLC39A8 | T | 0.035 | 19.12 | 48.20 | 0.6917 | 6.72 | 51.04 | 0.8953 |
| rs2112347 | FLJ35779 | G | 0.279 | −35.84 | 19.26 | 0.0628 | −32.21 | 18.74 | 0.0856 |
| rs6864049 | ZNF608 | A | 0.269 | −40.31 | 27.00 | 0.1354 | −34.92 | 26.34 | 0.1848 |
| rs206936 | NUDT3 | G | 0.231 | −9.46 | 21.60 | 0.6613 | −11.54 | 19.48 | 0.5537 |
| rs987237 | TFAP2B | G | 0.133 | 63.66 | 32.82 | 0.0524 | 58.51 | 33.66 | 0.0821 |
| rs10968576 | LRRN6C | G | 0.166 | −11.57 | 37.86 | 0.7599 | 0.46 | 35.74 | 0.9898 |
| rs4929949 | RPL27A | C | 0.355 | −29.48 | 27.51 | 0.2840 | −36.44 | 25.37 | 0.1509 |
| rs2030323 | BDNF | T | 0.112 | −106.06 | 33.13 | 0.0014†† | −96.75 | 35.31 | 0.0061† |
| rs3817334 | MTCH2 | T | 0.257 | −2.68 | 34.79 | 0.9387 | −2.78 | 34.38 | 0.9356 |
| rs7138803 | FAIM2 | A | 0.213 | 22.09 | 25.07 | 0.3783 | 23.81 | 25.10 | 0.3428 |
| rs7359397 | SH2B1 | T | 0.230 | 10.54 | 25.46 | 0.6789 | 14.35 | 25.13 | 0.5679 |
| rs11847697 | PRKD1 | T | 0.062 | 23.43 | 48.19 | 0.6269 | 17.61 | 48.50 | 0.7165 |
| rs17109256 | NRXN3 | A | 0.130 | 3.30 | 46.42 | 0.9433 | 2.85 | 45.95 | 0.9505 |
| rs2241423 | MAP2K5 | A | 0.225 | −15.05 | 35.23 | 0.6693 | −4.14 | 34.99 | 0.9059 |
| rs1885988 | MTIF3 | G | 0.084 | 23.35 | 39.73 | 0.5567 | 18.94 | 40.16 | 0.6372 |
| rs12444979 | GPRC5B | T | 0.061 | 126.22 | 38.24 | 0.0010†† | 117.41 | 32.51 | 0.0003†† |
| rs1421085 | FTO | C | 0.240 | 38.49 | 23.27 | 0.0981 | 24.31 | 23.37 | 0.2981 |
| rs571312 | MC4R | T | 0.159 | 61.32 | 26.24 | 0.0194† | 58.84 | 24.85 | 0.0179† |
| rs29941 | KCTD15 | T | 0.210 | −22.96 | 26.60 | 0.3882 | −17.57 | 26.15 | 0.5017 |
| rs2287019 | QPCTL | T | 0.104 | −15.84 | 34.67 | 0.6478 | −2.00 | 32.36 | 0.9508 |
| rs2303108 | TMEM160 | T | 0.242 | −32.38 | 23.18 | 0.1626 | −35.57 | 22.14 | 0.1081 |
PCs: principal components reflecting genetic ancestry.
Results from multivariable linear regression with a Huber-White sandwich estimator; beta weight per copy of the minor allele.
indicates nominal significance (0.0016 ≤ p < 0.05).
indicates significance after Bonferroni correction (p < 0.0016)
Obesity risk alleles in the MC4R region were also nominally associated with total caloric intake. The minor allele at MC4R rs571312, related to greater risk for obesity, was associated with greater total caloric intake per day per copy (β=61.32, SE=26.24; P=0.0194; weight adjusted: β=58.84, SE=24.85; P = 0.0179). In addition to SNPs previously associated with dietary intake, a significant association between the minor (T) allele at GPRC5B rs12444979 and greater total caloric intake emerged in the full sample. However, the direction of association was inconsistent with prior reports for obesity, in which the major allele was associated with increased risk.
The associations of BDNF rs2030323 with dietary intake appeared stronger in the largest racial/ethnic subgroup, non-Hispanic White individuals (Table 3). The protective minor allele was again associated with fewer calories per day per copy, achieving statistical significance before and after statistical adjustment for body weight (β=−151.99, SE=30.09; P<0.0001; weight adjusted: β=−140.49, SE=31.75; P<0.0001).
Table 3.
Association of the minor allele at each obesity associated SNP with total caloric intake in non-Hispanic White participants (N=1796).
| SNP | Closest Gene |
Minor allele |
MAF | Adjusted for age, sex, study site, PCs |
Adjusted for age, sex, study site, PCs and weight |
||||
|---|---|---|---|---|---|---|---|---|---|
| Beta* | Std Err | ProbT | Beta* | Std Err | ProbT | ||||
| rs2815752 | NEGR1 | C | 0.24 | 35.34 | 21.50 | 0.1002 | 39.58 | 19.49 | 0.0423 |
| rs1514175 | TNNI3K | T | 0.31 | 17.06 | 22.22 | 0.4426 | 16.40 | 21.73 | 0.4503 |
| rs11165643 | PTBP2 | C | 0.27 | 27.57 | 28.14 | 0.3271 | 32.20 | 28.79 | 0.2632 |
| rs543874 | SEC16B | T | 0.12 | −7.56 | 33.00 | 0.8187 | −13.49 | 28.75 | 0.6390 |
| rs2867125 | TMEM18 | A | 0.10 | 38.42 | 51.25 | 0.4534 | 46.47 | 49.66 | 0.3494 |
| rs11676272 | RBJ | G | 0.36 | 5.43 | 23.83 | 0.8199 | 8.64 | 24.49 | 0.7244 |
| rs887912 | FANCL | A | 0.19 | 12.30 | 30.26 | 0.6843 | 12.41 | 30.03 | 0.6794 |
| rs9852859 | CADM2 | C | 0.12 | −72.75 | 41.76 | 0.0815 | −78.25 | 45.03 | 0.0822 |
| rs9816226 | ETV5 | A | 0.11 | 86.02 | 34.40 | 0.0124† | 86.85 | 34.83 | 0.0126† |
| rs12641981 | GNPDA | T | 0.32 | −4.36 | 32.75 | 0.8940 | −15.43 | 29.91 | 0.6058 |
| rs13107325 | SLC39A8 | T | 0.05 | 37.49 | 45.84 | 0.4135 | 25.95 | 46.89 | 0.5800 |
| rs2112347 | FLJ35779 | G | 0.24 | −29.03 | 30.03 | 0.3336 | −28.44 | 29.95 | 0.3423 |
| rs6864049 | ZNF608 | A | 0.35 | −31.73 | 32.59 | 0.3303 | −21.47 | 31.30 | 0.4929 |
| rs206936 | NUDT3 | G | 0.12 | 0.72 | 36.49 | 0.9842 | 4.64 | 31.49 | 0.8829 |
| rs987237 | TFAP2B | G | 0.12 | 76.66 | 35.37 | 0.0302† | 74.95 | 35.28 | 0.0336† |
| rs10968576 | LRRN6C | G | 0.21 | 40.74 | 31.39 | 0.1944 | 39.16 | 30.63 | 0.2011 |
| rs4929949 | RPL27A | C | 0.37 | −39.86 | 21.55 | 0.0644 | −44.07 | 20.26 | 0.0297 |
| rs2030323 | BDNF | T | 0.13 | −151.99 | 30.09 | <.0001†† | −140.49 | 31.75 | <.0001†† |
| rs3817334 | MTCH2 | T | 0.28 | −18.40 | 34.01 | 0.5885 | −24.40 | 33.18 | 0.4622 |
| rs7138803 | FAIM2 | A | 0.27 | 4.42 | 20.44 | 0.8288 | 9.05 | 19.82 | 0.6479 |
| rs7359397 | SH2B1 | T | 0.27 | 20.09 | 28.35 | 0.4785 | 22.04 | 29.31 | 0.4521 |
| rs11847697 | PRKD1 | T | 0.02 | −6.73 | 59.14 | 0.9094 | −8.38 | 61.68 | 0.8919 |
| rs17109256 | NRXN3 | A | 0.14 | −21.89 | 39.94 | 0.5837 | −24.43 | 38.65 | 0.5274 |
| rs2241423 | MAP2K5 | A | 0.14 | −10.87 | 40.18 | 0.7867 | 4.70 | 40.01 | 0.9065 |
| rs1885988 | MTIF3 | G | 0.12 | 33.26 | 44.59 | 0.4557 | 30.89 | 44.20 | 0.4846 |
| rs12444979 | GPRC5B | T | 0.08 | 29.25 | 31.04 | 0.3461 | 36.64 | 28.87 | 0.2044 |
| rs1421085 | FTO | C | 0.34 | 56.72 | 20.69 | 0.0061† | 47.54 | 22.19 | 0.0322† |
| rs571312 | MC4R | T | 0.16 | 60.02 | 36.86 | 0.1035 | 49.14 | 36.01 | 0.1723 |
| rs29941 | KCTD15 | T | 0.20 | −22.58 | 42.08 | 0.5916 | −20.99 | 42.07 | 0.6179 |
| rs2287019 | QPCTL | T | 0.12 | −20.53 | 27.33 | 0.4525 | −9.95 | 28.42 | 0.7262 |
| rs2303108 | TMEM160 | T | 0.19 | −11.74 | 32.50 | 0.7180 | −12.75 | 30.04 | 0.6713 |
PCs: principal components reflecting genetic ancestry.
Results from multivariable linear regression with a Huber-White sandwich estimator; beta weight per copy of the minor allele.
indicates nominal significance (0.0016 ≤ p < 0.05).
indicates significance after Bonferroni correction (p < 0.0016)
Moreover, some evidence for the association of the FTO region with total caloric intake was observed. In the non-Hispanic White participants only (Table 3), the obesity risk allele at FTO rs1421085 was associated with higher caloric intake at the level of nominal significance (β=56.72, SE=20.69; P=0.0061). The effect was weakened somewhat by further statistical adjustment for body weight but still achieved nominal significance (β=47.54, SE=22.19; P=0.0322). The association of FTO with total caloric intake was not significant in the full sample.
Nominal associations of the TFAP2B rs987237 and ETV5 rs9816226 with greater total caloric intake was observed in the non-Hispanic White subsample but only TFAP2B rs987237 was in a direction consistent with the previously reported association of the major allele with obesity. Although of similar magnitude as in the full sample, the association of MC4R rs571312 with total caloric intake did not achieve significance in the non-Hispanic White subgroup.
Percent of calories from fat, carbohydrate and protein
No association reached statistical significance in the full sample. However, consistent with prior findings [10,14,18], a nominal association between the obesity-associated, minor allele at FTO rs1421085 and greater percentage fat intake (β=0.37, SE=0.08; P=0.0418) was observed in the non-Hispanic White participants only. The minor allele at FLJ35779 rs2112347 was further associated with lower percentage protein intake (β=−0.30, SE=0.09; P=0.0006) in this subsample.
Number of meals and snacks per day
Contrary to previous findings, no SNPs were associated with number of eating episodes at a level of statistical significance after multiple comparison correction in the full sample or non-Hispanic White participants. No replications of prior results were observed even at the nominal level of statistical significance.
Food Guide pyramid food groups
No associations of obesity risk alleles with servings from specific Food Guide pyramid groups reached statistical significance in the full sample. In non-Hispanic White participants, the minor allele at BDNF rs2030323, associated with lower risk for obesity, was significantly associated with fewer daily servings of breads, cereals, rice and pasta (PFG1; β =−0.27, SE=0.07, P = 0.0001) and meats, eggs, nuts and beans (PFG5, β =−0.16, SE=0.04, P < 0.0001), with nominal associations with fewer servings of vegetables (PFG2; β =−0.14, SE=0.06, P= 0.0164) and fats, oils and sweets (PFG6, β =−0.20, SE=0.10, P=0.0340). Partial replication at a nominally significant level was also observed for the association of the obesity risk allele at FTO 1421085 and more servings of fats, oils and sweets (PFG6, β =0.18, SE=0.08, P=0.0327). Statistical adjustment for total caloric intake largely diminished these associations, suggesting that any genetic associations with servings within these food groups were likely mediated via previously-noted effects on total caloric intake. No other statistically significant associations with daily servings from specific food groups were observed in non-Hispanic White participants.
Weighted genetic risk score
A genetic risk score comprised of the number of risk alleles at each locus weighted by the prior association of the locus with body weight was calculated to determine association with the dietary intake. No significant association with any dietary parameter was observed in the full sample or non-Hispanic white participants (Table S1, Supplemental Digital Content 1).
Discussion
An increasing number of studies indicate that several obesity risk variants identified through GWAS may affect weight by affecting dietary intake [9–14,16–18]. Replication of these initial results is critical, as reports of genetic associations often turn out to be false positive and several of the reported associations have been inconsistent thus far. Here, we establish common variants in the BDNF region as replicated predictors of total caloric intake as assessed by FFQ in the Diabetes Prevention Program, including 3,180 overweight or obese individuals at risk for diabetes. Moreover, in direct replication of prior research but of nominal statistical significance in this cohort, we provide further evidence for association of the MC4R obesity risk region with total caloric intake in the full sample, and for association of the FTO obesity risk region with total caloric intake, percent fat intake and number of daily servings of fats and sweets among non-Hispanic White individuals.
Rigorous replication of original findings is critical because it helps to arbitrate whether a result reflects a “true positive” or simply reflects statistical chance. Although how to firmly decide what is a “true positive” is open to debate, independent replication in two cohorts using similar methodology reduces the statistical chance of a false positive result as well as increases confidence that the result is not specific to a given sample.
BDNF and its primary receptor TrkB are expressed in key regions of the hypothalamus and dorsal vagal complex related to body weight and energy homeostasis [34–38]. Targeted disruption of BDNF in transgenic mice results in hyperphagia and obesity [39–43]. BDNF rs6265, in linkage disequilibrium with rs2030323, leads to a valine to methionine substitution at position 66 (Val66Met) in the prodomain of the gene [44]. In Look AHEAD, the minor, obesity-protective allele at BDNF rs6265 predicted fewer servings of meats, eggs, nuts and beans (PFG5) with nominal but directionally consistent associations with total caloric intake, servings of breads, cereals, rice and pasta (PFG1) and servings of sweets and fats (PFG6) [18]. Furthermore, at least one case study also links rare mutations in BDNF to hyperphagia and severe obesity in an 8-year-old girl [45]. It is interesting that the BDNF obesity risk region was not associated with total caloric intake in a sample of Dutch women, but the SNP markers were in lower linkage disequilibrium with the present SNP (rs2030323, rs1488830, r2 = 0.91 CEU; rs2030323, rs925946, r2=0.20, CEU).
The obesity risk allele at MC4R rs571312 was nominally associated with total caloric intake, in replication of research in the Nurses’ Health Study [15] and men and women of Scottish descent [16]. Variation at this MC4R region was not associated with dietary measures in Look AHEAD [18]. Nonetheless, the present result complements prior literature demonstrating that rare variants in MC4R contribute to hyperphagia [46] and adds to at least two other papers [15,16] extending associations with dietary intake to common variants.
With regard to the FTO region, we found evidence for replication of associations with total caloric intake, percentage fat intake and number of daily servings from Pyramid Food Group 6, fats and sweets, but associations were limited to the non-Hispanic White subsample of DPP. It is notable that this region was discovered as a predictor of obesity in populations predominately of European ancestry [12–14]. Although it now appears that the obesity risk region in intron 1 of FTO is also associated with obesity in populations of African and Hispanic descent, together accounting for roughly 37% of DPP, associations show smaller effect sizes, and the pattern of linkage disequilibrium differs [30,31]. Thus, it may be more difficult to detect associations with the FTO region in samples with diverse racial and ethnic backgrounds. We did not replicate the association of the FTO region with number of meals and snacks, suggesting that this parameter of dietary intake is unlikely to account for associations with obesity.
BDNF genotype were associated with an increase of roughly 100 – 150 kcals per one risk allele per day, and 200 – 300 kcals per day for two risk alleles. The MC4R region was further associated with roughly 60 kcals per one allele and 120 kcals per two alleles per day, with an additional roughly 50 and 100 kcals per day for carriers of one and two risk alleles in the FTO obesity risk region in non-Hispanic Whites. Tracking the rise in weight in the U.S., and employing the formula that 3,500 kcals of excess intake translates to one additional pound of body weight, Hill and colleagues [19] estimated that the obesity epidemic was attributable to roughly 100 kcal difference in energy balance per day. These genetic effects described in this paper fall well within that range and may contribute to weight gain patterns in the U.S. Indeed, successful clinical programs prescribing a 100 kcal change in energy balance each day to prevent weight gain have emerged [20,21]. Thus, it may be plausible to target high-risk allele carriers with such approaches to prevent weight gain. At the same time, it will be important to acknowledge that dietary intake is not the only driver of weight gain and the impact of physical activity, resting energy expenditure and other homeostatic mechanisms will also contribute to how excess dietary intake contributes to weight gain.
It remains quite plausible that additional obesity-associated regions may predict patterns of dietary intake, although demonstration of association is likely to require large sample sizes given the small effect size in relation to obesity [6]. Nonetheless, the biologic function of several of these gene regions and phenotypic expression of hyperphagia in rare monogenic disorders for SH2B1 and POMC, for example, strongly points to their role in central nervous system eating pathways [8]. Indeed, the most recent genome-wide association study of obesity, identifying 65 novel obesity-associated loci but of even smaller effect size than those tested here, found BMI-associated loci to contribute almost exclusively to pathways enriched for expression in the brain and central nervous system [47]. These pathways were not limited to hypothalamic pathways, but also included hippocampal and limbic structures, suggesting that constructs such as learning, memory and emotion may contribute to the genetics of eating together with homeostatic mechanisms.
Strengths of this study include targeted replication analyses in a racially and ethnically diverse sample of men and women, control for population stratification, and a validated food frequency questionnaire. Limitations include a selected cohort of individuals at risk for diabetes and a sample size that may have prevented us from detecting small magnitude effects in the full sample and evaluating differences and similarities across the diverse racial and ethnic participants. The measurement of dietary intake also has limitations. The U.S. Department of Agriculture 5-pass method, 24-hour dietary recall, is considered to be the gold standard of dietary assessment [48,49]. However, in large samples FFQs are usually used to assess dietary intake over a specified time period due to their low cost, ease of administration [50] and prior validation by 24-hour dietary recall [51]. Much of the prior research on genetic associations with dietary intake has relied upon FFQs so measurement in this study is largely consistent with the prior literature [12–18]. Nonetheless, as with most measures of self-reported dietary intake, it is important to recognize that under-reporting is common [52–55].
In summary, our results establish replication of common alleles within BDNF as predictors of total caloric intake, and provide additional, confirmatory evidence of association of the MC4R and FTO obesity risk regions with dietary intake. These results build upon the key role of BDNF and MC4R in hypothalamic eating pathways as well as prior associations of rare variants within these genes with hyperphagia, and prior associations of FTO with caloric and fat intake. Future research is warranted to explore whether clinical interventions can mitigate obesity risk in BDNF and potentially MC4R, as well as address potential racial and ethnic differences in association, particularly for the FTO region.
Supplementary Material
Acknowledgments
Diabetes Prevention Program: The NIDDK of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study; collection, management, analysis, and interpretation of the data. The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources supported data collection at many of the clinical centers. Funding for data collection and participant support was also provided by the Office of Research on Minority Health, the National Institute of Child Health and Human Development, the National Institute on Aging, the Centers for Disease Control and Prevention, Office of Research on Women's Health, the Department of Veterans Affairs, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided medication. This research was also supported, in part, by the intramural research program of the NIDDK. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. The opinions expressed are those of the investigators and do not necessarily reflect the views of the Indian Health Service or other funding agencies. A complete list of Centers, investigators, and staff can be found in the online Appendix, Supplemental Digital Content 2.
The investigators gratefully acknowledge the commitment and dedication of all participants in the DPP; without whom this work would not have been possible. This work was funded by R01 DK072041-02 to JCF, KAJ (PWF and WCK are co-investigators). PWF has support by grants from Novo Nordisk, the Swedish Research Council, the Swedish Heart-Lung Foundation and the Swedish Diabetes Association. SEK is supported in part by the Department of Veterans Affairs. JCF is supported a Doris Duke Charitable Foundation Clinical Scientist Development Award.
Abbreviations
- BMI
body mass index
- DPP
Diabetes Prevention Program
- FFQ
food frequency questionnaire
- GWAS
genome-wide association study
- Kcal
kilocalories
- MAF
minor allele frequency
- SNP
single nucleotide polymorphism
- BDNF
brain-derived neurotrophic factor gene symbol
- MC4R
melanocortin 4 receptor gene symbol
- FTO
fat mass and obesity associated gene symbol
Footnotes
LMD has a financial interest in Omada Health, a company that develops online behavior-change programs, with a focus on diabetes. LMD's interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. No other potential conflict of interest is declared by any author.
JMM and KAJ designed the research; WCK, RRW, LMD, VA, DM, RFH, EH, SDJ, JWR, EBC, AK and JCF conducted research; KAJ analyzed data; all authors contributed to writing the paper; JMM and KAJ had primary responsibility for final content. All authors read and approved the final manuscript.
Contributor Information
Jeanne M. McCaffery, Weight Control and Diabetes Research Center, The Miriam Hospital and Warren Alpert School of Medicine at Brown University; Providence, R.I.
Kathleen A. Jablonski, The Biostatistics Center, The George Washington University, Rockville, MD
Paul W. Franks, Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden; Department of Medicine, Umeå University, Umeå, Sweden; Department of Nutrition, Harvard School of Public Health, Boston, MA.
Linda M. Delahanty, Massachusetts General Hospital Diabetes Center, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA
Vanita Aroda, Medstar Health Research Institute; Hyattsville, MD
David Marrero, Indiana University; Indianapolis, IN
Richard F. Hamman, Colorado School of Public Health, Department of Epidemiology, University of Colorado Denver; Aurora, CO
Edward S. Horton, Joslin Diabetes Center; Boston, MA
Samuel Dagogo-Jack, University of Tennessee, Memphis, TN
Judith Wylie-Rosett, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
Elizabeth Barrett-Connor, University of California San Diego; La Jolla, CA
Abbas Kitabchi, University of Pittsburgh; Pittsburgh, PA
William C. Knowler, Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ
Rena R. Wing, Weight Control and Diabetes Research Center, The Miriam Hospital and Warren Alpert School of Medicine at Brown University; Providence, R.I.
Jose C. Florez, Diabetes Research Center (Diabetes Unit and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA
References
- 1.Cannon CP. Obesity-related cardiometabolic complications. Clin Cornerstone. 2008;9:11–19. doi: 10.1016/s1098-3597(08)60024-1. [DOI] [PubMed] [Google Scholar]
- 2.Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555. doi: 10.1001/jama.295.13.1549. [DOI] [PubMed] [Google Scholar]
- 3.Vanltallie TB, Abraham S. Some hazards of obesity and its treatment. In: Hirsch J, VanItallie TB, editors. Recent Advances in Obesity Research. London: Libbey; 1985. pp. 1–19. [Google Scholar]
- 4.Pi Sunyer FX. Medical hazards of obesity. Annals of Internal Medicine. 1993;119:655–660. doi: 10.7326/0003-4819-119-7_part_2-199310011-00006. [DOI] [PubMed] [Google Scholar]
- 5.Colditz GA. Economic costs of obesity. American Journal of Clinical Nutrition. 1992;55:503–507. doi: 10.1093/ajcn/55.2.503s. [DOI] [PubMed] [Google Scholar]
- 6.Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–948. doi: 10.1038/ng.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, Jonsdottir T, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Jonsson F, Borch-Johnsen K, Hansen T, Andersen G, Jorgensen T, Lauritzen T, Aben KK, Verbeek AL, Roeleveld N, Kampman E, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Becker DM, Gulcher J, Kiemeney LA, Pedersen O, Kong A, Thorsteinsdottir U, Stefansson K. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24. doi: 10.1038/ng.274. [DOI] [PubMed] [Google Scholar]
- 8.Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, Lettre G, Lim N, Lyon HN, McCarroll SA, Papadakis K, Qi L, Randall JC, Roccasecca RM, Sanna S, Scheet P, Weedon MN, Wheeler E, Zhao JH, Jacobs LC, Prokopenko I, Soranzo N, Tanaka T, Timpson NJ, Almgren P, Bennett A, Bergman RN, Bingham SA, Bonnycastle LL, Brown M, Burtt NP, Chines P, Coin L, Collins FS, Connell JM, Cooper C, Smith GD, Dennison EM, Deodhar P, Elliott P, Erdos MR, Estrada K, Evans DM, Gianniny L, Gieger C, Gillson CJ, Guiducci C, Hackett R, Hadley D, Hall AS, Havulinna AS, Hebebrand J, Hofman A, Isomaa B, Jacobs KB, Johnson T, Jousilahti P, Jovanovic Z, Khaw KT, Kraft P, Kuokkanen M, Kuusisto J, Laitinen J, Lakatta EG, Luan J, Luben RN, Mangino M, McArdle WL, Meitinger T, Mulas A, Munroe PB, Narisu N, Ness AR, Northstone K, O'Rahilly S, Purmann C, Rees MG, Ridderstrale M, Ring SM, Rivadeneira F, Ruokonen A, Sandhu MS, Saramies J, Scott LJ, Scuteri A, Silander K, Sims MA, Song K, Stephens J, Stevens S, Stringham HM, Tung YC, Valle TT, Van Duijn CM, Vimaleswaran KS, Vollenweider P, Waeber G, Wallace C, Watanabe RM, Waterworth DM, Watkins N, Witteman JC, Zeggini E, Zhai G, Zillikens MC, Altshuler D, Caulfield MJ, Chanock SJ, Farooqi IS, Ferrucci L, Guralnik JM, Hattersley AT, Hu FB, Jarvelin MR, Laakso M, Mooser V, Ong KK, Ouwehand WH, Salomaa V, Samani NJ, Spector TD, Tuomi T, Tuomilehto J, Uda M, Uitterlinden AG, Wareham NJ, Deloukas P, Frayling TM, Groop LC, Hayes RB, Hunter DJ, Mohlke KL, Peltonen L, Schlessinger D, Strachan DP, Wichmann HE, McCarthy MI, Boehnke M, Barroso I, Abecasis GR, Hirschhorn JN. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34. doi: 10.1038/ng.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558–2566. doi: 10.1056/NEJMoa0803839. [DOI] [PubMed] [Google Scholar]
- 10.Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, McCarthy MI, Davey Smith G. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr. 2008;88:971–978. doi: 10.1093/ajcn/88.4.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93:3640–3643. doi: 10.1210/jc.2008-0472. [DOI] [PubMed] [Google Scholar]
- 12.Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, Frazier-Wood AC, et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013;97:1395–1402. doi: 10.3945/ajcn.112.052183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chu AY, Workalemahu T, Paynter NP, Rose LM, Giulianini F, Tanaka T, Ngwa JS, Qi Q, Curhan GC, Rimm EB, Hunter DJ, Pasquale LR, Ridker PM, Hu FB, Chasman DI, Qi L. Novel locus including FGF21 is associated with dietary macronutrient intake. Hum Mol Genet. 2013;22:1895–1902. doi: 10.1093/hmg/ddt032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Park SL, Cheng I, Pendergrass SA, Kucharska-Newton AM, Lim U, Ambite JL, Caberto CP, Monroe KR, Schumacher F, Hindorff LA, Oetjens MT, Wilson S, Goodloe RJ, Love SA, Henderson BE, Kolonel LN, Haiman CA, Crawford DC, North KE, Heiss G, Ritchie MD, Wilkens LR, Le Marchand L. Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study. Am J Epidemiol. 2013;178:780–790. doi: 10.1093/aje/kwt028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Qi L, Kraft P, Hunter DJ, Hu FB. The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet. 2008;17:3502–3508. doi: 10.1093/hmg/ddn242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tenesa A, Campbell H, Theodoratou E, Dunlop L, Cetnarskyj R, Farrington SM, Dunlop MG. Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. Int J Obes (Lond) 2009;33:284–288. doi: 10.1038/ijo.2008.257. [DOI] [PubMed] [Google Scholar]
- 17.Bauer F, Elbers CC, Adan RA, Loos RJ, Onland-Moret NC, Grobbee DE, van Vliet-Ostaptchouk JV, Wijmenga C, van der Schouw YT. Obesity genes identified in genome-wide association studies are associated with adiposity measures and potentially with nutrient-specific food preference. Am J Clin Nutr. 2009;90:951–959. doi: 10.3945/ajcn.2009.27781. [DOI] [PubMed] [Google Scholar]
- 18.McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, Cheskin LJ, Balasubramanyam A, Wagenknecht LE, Wing RR. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012;95:1477–1486. doi: 10.3945/ajcn.111.026955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hill JO, Astrup A. What diets should we be recommending for obesity? Obes Rev. 2003;4:77–78. doi: 10.1046/j.1467-789x.2003.00103.x. [DOI] [PubMed] [Google Scholar]
- 20.Rodearmel SJ, Wyatt HR, Barry MJ, Dong F, Pan D, Israel RG, Cho SS, McBurney MI, Hill JO. A family-based approach to preventing excessive weight gain. Obesity (Silver Spring) 2006;14:1392–1401. doi: 10.1038/oby.2006.158. [DOI] [PubMed] [Google Scholar]
- 21.Rodearmel SJ, Wyatt HR, Stroebele N, Smith SM, Ogden LG, Hill JO. Small changes in dietary sugar and physical activity as an approach to preventing excessive weight gain: the America on the Move family study. Pediatrics. 2007;120:e869–e879. doi: 10.1542/peds.2006-2927. [DOI] [PubMed] [Google Scholar]
- 22.Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. doi: 10.1056/NEJMoa012512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623–634. doi: 10.2337/diacare.22.4.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mayer-Davis EJ, Sparks KC, Hirst K, Costacou T, Lovejoy JC, Regensteiner JG, Hoskin MA, Kriska AM, Bray GA. Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. Ann Epidemiol. 2004;14:763–772. doi: 10.1016/j.annepidem.2004.02.004. [DOI] [PubMed] [Google Scholar]
- 25.The Food Guide Pyramid. Washington DC: US Department of Agriculture Center for Nutrition Policy and Promotion; 2000. [Google Scholar]
- 26.Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN, Karter AJ. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) Am J Clin Nutr. 1997;65:79–87. doi: 10.1093/ajcn/65.1.79. [DOI] [PubMed] [Google Scholar]
- 27.Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938–2939. doi: 10.1093/bioinformatics/btn564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Huber PJ. The behavior of maximum liklihood estimates under nonstandard conditions. Proceedings of the Fifth Berkley Symposium on Mathematical Statisitics and Probability. 1967;I:221–233. [Google Scholar]
- 29.Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–909. doi: 10.1038/ng1847. [DOI] [PubMed] [Google Scholar]
- 30.Loos RJ, Yeo GS. The bigger picture of FTO--the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10:51–61. doi: 10.1038/nrendo.2013.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Peters U, North KE, Sethupathy P, Buyske S, Haessler J, Jiao S, Fesinmeyer MD, Jackson RD, Kuller LH, Rajkovic A, Lim U, Cheng I, Schumacher F, Wilkens L, Li R, Monda K, Ehret G, Nguyen KD, Cooper R, Lewis CE, Leppert M, Irvin MR, Gu CC, Houston D, Buzkova P, Ritchie M, Matise TC, Le Marchand L, Hindorff LA, Crawford DC, Haiman CA, Kooperberg C. A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study. PLoS Genet. 2013;9:e1003171. doi: 10.1371/journal.pgen.1003171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Yang TL, Guo Y, Li SM, Li SK, Tian Q, Liu YJ, Deng HW. Ethnic differentiation of copy number variation on chromosome 16p12.3 for association with obesity phenotypes in European and Chinese populations. Int J Obes (Lond) 2013;37:188–190. doi: 10.1038/ijo.2012.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW Diabetes Prevention Program Research Group. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 2012;35:363–366. doi: 10.2337/dc11-1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bariohay B, Lebrun B, Moyse E, Jean A. Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology. 2005;146:5612–5620. doi: 10.1210/en.2005-0419. [DOI] [PubMed] [Google Scholar]
- 35.Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology. 2009;150:2646–2653. doi: 10.1210/en.2008-1184. [DOI] [PubMed] [Google Scholar]
- 36.Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609–642. doi: 10.1146/annurev.biochem.72.121801.161629. [DOI] [PubMed] [Google Scholar]
- 37.Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton Neurosci. 2006;126–127:30–38. doi: 10.1016/j.autneu.2006.02.027. [DOI] [PubMed] [Google Scholar]
- 38.Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci. 1997;17:2295–2313. doi: 10.1523/JNEUROSCI.17-07-02295.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Fox EA, Byerly MS. A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants. Am J Physiol Regul Integr Comp Physiol. 2004;286:R994–R1004. doi: 10.1152/ajpregu.00727.2003. [DOI] [PubMed] [Google Scholar]
- 40.Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000;19:1290–1300. doi: 10.1093/emboj/19.6.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A. 1999;96:15239–15244. doi: 10.1073/pnas.96.26.15239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci. 2007;27:14265–14274. doi: 10.1523/JNEUROSCI.3308-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci. 2003;6:736–742. doi: 10.1038/nn1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257–269. doi: 10.1016/s0092-8674(03)00035-7. [DOI] [PubMed] [Google Scholar]
- 45.Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'Rahilly S, Farooqi IS. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55:3366–3371. doi: 10.2337/db06-0550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348:1085–1095. doi: 10.1056/NEJMoa022050. [DOI] [PubMed] [Google Scholar]
- 47.Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206. doi: 10.1038/nature14177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Subar AF, Kipnis V, Troiano RP, Midthune D, Scoeller DA, Bingham S, Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, Sunshine J, Schatzkin A. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: The OPEN study. American Journal of Epidemiology. 2003;158:1–13. doi: 10.1093/aje/kwg092. [DOI] [PubMed] [Google Scholar]
- 49.Shai I, Rosner BA, Shahar DR, Vardi H, Azrad AB, Kanfi A, Schwarzfuchs D, Fraser D. Dietary evaluation and attenuation of relative risk: Multiple comparisons between blood and urinary biomarkers, food frequency, and 24-hour recall questionnaires: the DEARR Study. Journal of Nutrition. 2005;135:573–579. doi: 10.1093/jn/135.3.573. [DOI] [PubMed] [Google Scholar]
- 50.Tooze JA, Subar AF, Thompson FE, Troiano R, Schatzkin A, Kipnis V. Psychosocial predictors of energy underreporting in a large doubly labeled water study. American Journal of Clinical Nutrition. 2004;79:795–804. doi: 10.1093/ajcn/79.5.795. [DOI] [PubMed] [Google Scholar]
- 51.Mayer-Davis EJ, Vitolins MZ, Carmichael SL, Hemphill S, Tsaroucha G, Rushing J, Levin S. Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol. 1999;9:314–324. doi: 10.1016/s1047-2797(98)00070-2. [DOI] [PubMed] [Google Scholar]
- 52.Bedard D, Shatenstien B, Nadon S. Underreporting of energy intake from a self-administered food-frequency questionnaire completed by adults in Montreal. Public Health Nutrition. 2003;7:675–681. doi: 10.1079/PHN2003578. [DOI] [PubMed] [Google Scholar]
- 53.Johansson L, Solvoll K, Aa Bjorneboe GE, Drevon CA. Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. American Journal of Clincal Nutrition. 1998;68:266–274. doi: 10.1093/ajcn/68.2.266. [DOI] [PubMed] [Google Scholar]
- 54.Olafsdottir AS, Thorsdottir I, Gunnarsdottir I, Thorgeirsdottir H, Steingrimsdottir L. Comparison of women's diet assessed by FFQs and 24-hour recalls with and without underreporters: Associations and biomarkers. Annals of Nutrition & Metabolism. 2006;50:450–460. doi: 10.1159/000094781. [DOI] [PubMed] [Google Scholar]
- 55.Yannakoulia M, Panagiotakos DB, Pitsavos C, Bathrellou E, Chrysohoou C, Skoumas Y, Stefanadis C. Low energy reporting related to lifestyle, clinical, and pychosocial factors in a randomly selected population sample of Greek adults: The ATTICA study. Journal of the American College of Nutrition. 2007;26:327–333. doi: 10.1080/07315724.2007.10719619. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
